Anaplastic Lymphoma Kinase (ALK) is not Expressed in Hodgkin's Disease: Results with ALK-11 Antibody in 327 Untreated Patients

References

• Moms S. W., Kirstein M. N., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–4
   PubMed Web of Science ®Google Scholar
• Morris S. W., Naeve C., Mathew P., James P. L., Kirstein M. N., Cui X., Witte D. P. ALK, the chromosome 2 gene locus altered by the t(2; 5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 1997; 14: 2175–88
   PubMed Web of Science ®Google Scholar
• Downing J. R., Shurtleff S. A., Zielenska M., Curcio-Brint A. M., Behm F. G., Head D. R., Sandlund J. T., Weisenburger D. D., Kossakowska A. E., Thorner P., Lorenzana A., Ladanyi M., Morris S. W. Molecular detection of the (2; 5) translocation of Non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 1995; 85: 3416–22
   PubMed Web of Science ®Google Scholar
• Wellmann A., Otsuki T., Vogelbruch M., Clark H. M., Jaffe E. S., Raffeld M. Analysis of the t(2;5)(p23;q35) translocation by reverse transciption-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 1995; 86: 2321–2328
   PubMed Web of Science ®Google Scholar
• Waggott W., Lo Y.-M.D., Bastard C., Gatter K. C., Leroux D., Mason D. Y., Boultwood J., Wainscoat J. S. DNA and RNA studies of the NMP-ALK rearangement in Ki-1 positive anaplastic large cell lymphoma, diagnostic applications. Blood 1994; 84S: 442a
   Google Scholar
• Elmberger P. G., Lozano M. D., Weisenburger D. D., Sanger W., Chan W. C. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood 1995; 86: 3517–21
   PubMed Web of Science ®Google Scholar
• Lamant L., Meggetto F., al Saati T., Brugieres L., de Paillerets B. B., Dastugue N., Bernheim A., Ruble H., Terrier-Lacombe M. J., Robert A., Rigal F., Schlaifer D., Shiuta M., Mori S., Delsol G. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996; 87: 284–91
   PubMed Web of Science ®Google Scholar
• Sam's A.H., Luthra R., Papadimitracopoulou V., Waadsorp M., Dimopoulos M. A., McBride J. A., Cabanillas F., Duvic M., Deisseroth A., Morris S. W., Pugh W. C. Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not on other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood 1996; 88: 1771–1779
   PubMed Web of Science ®Google Scholar
• Morris S. W., Shurtleff S. A., Head D., Behm F. G., Raimondi S. C., Weisenburger D. D., Kossakowska A. E., Thorner P., Zielenski M., Lorenzana A., Ladanyi M., Downing J. R. Molecular detection of the t(2;5) of Non-Hodgkin's lymphoma (NHL) by reverse transcriptase-polymerase chain reaction. Blood 1994; 84(Suppl 1)37a
   Google Scholar
• Le Beau M. M., Bitter M. A., Larson R. A., Doane L. A., Ellis E. D., Franklin W. A., Rubin C. M., Kadin M. E., Vardiraan J. W. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 1989; 3: 866–70
   PubMed Web of Science ®Google Scholar
• Mason D. Y., Bastard C., Rimokh R., Dastugue N., Huret J. L., Kristoffersson U., Magaud J. P., Nezelof C., Tilly H., Vannier J. P., Hemet J., Warnke R. CD30-positive large cell lymphomas (“Ki-1 lymphoma”) are associated with a chromosomal translocation involving 5q35 [see comments]. Br J Haematol 1990; 74: 161–8
   PubMed Web of Science ®Google Scholar
• Shiota M., Fujimoto J., Takenaga M., Satoh H., Ichinohasama R., Abe M., Nakano M., Yamamoto T., Mori S. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994; 84: 3648–52
   PubMed Web of Science ®Google Scholar
• Shiota M., Nakaraura S., Ichinohasama R., Abe M., Akagi T, Takeshita M., Mori N., Fujimoto J., Miyauchi J., Mikata A., et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995; 86: 1954–60
   PubMed Web of Science ®Google Scholar
• Pulford K., Lamant L., Morris S. W., Butler L. H., Wood K. M., Stroud D., Delsol G., Mason D. Y. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997; 89: 1394–404
   PubMed Web of Science ®Google Scholar
• Pittaluga S., Wiodarska I., Pulford K., Campo E., Morris S. W., Van den Berghe H., De Wolf-Peeters C. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. American Journal of Pathology 1997; 151: 343–51
   PubMed Web of Science ®Google Scholar
• Lamant L., Dastugue N., Pulford K., Delsol G., Mariame B. A new fusion gene, TPM3-ALK, in anaplastic large-cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 1999; 93: 3088–3095
   PubMed Web of Science ®Google Scholar
• Hernandez L., Pinyol M., Hernandez S., Bea S., Pulford K., Rosenwald A., Lamant L., Falini B., Ott G., Mason D. Y., Delsol G., Campo E. TPK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood 1999; 94: 3265–3268
   PubMed Web of Science ®Google Scholar
• Ma Z., Cools J., Marynen P., Cui X., Siebert R., Gesk S., Schlegelberger B., Peelers B., De Wolf-Peeters C., Wiodarska I.S.W. M. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood 2000; 95: 2144–2149
   PubMed Web of Science ®Google Scholar
• Touriol C., Greenland C., Lamant L., Pulford K., Bernard R, Rousset T, Mason D., Delsol G. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 2000; 95: 3204–3207
   PubMed Web of Science ®Google Scholar
• Stein H., Herbst H., Anagnostopoulos I., Niedobitek G., Dallenbach F., Kratzsch H. C. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Am Oncol 1991; 2: 33–8
   Google Scholar
• Stein H., Dallenbach F. Diffuse large cell lymphomas of B and T cell type. Neoplastic Hematopathology, D.M. Knowles. Williams and Wilkins, Baltimore 1992; 675–714
   Google Scholar
• Leoncini L., Del Vecchio M. T., Kraft R., Megha T., Barbini P., Cevenini G., Poggi S., Pileri S., Tosi P., Cottier H. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas-a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. American Journal of Pathology 1990; 137: 1047–57
   PubMed Web of Science ®Google Scholar
• Orscheschek K., Merz H., Hell J., Binder T, Bartels H., Feller A. F. Large-cell anaplastic lymphoma-specific translocation (t[2;5] p23;q35]) in Hodgkin's disease: indication of a common pathogenesis?. The Lancet 1995; 345: 87–90
   PubMed Web of Science ®Google Scholar
• Bulkich F., Morris S. W., Hummel M., Pileri S., Stein H., Croce C. M. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Research 1994; 54: 2873–7
   PubMed Web of Science ®Google Scholar
• Ngan B. The presence of transcripts of the fusion of kinase gene ALK to nucleophosmin gene NPM in the t(2;5)(p23;q35) translocation defines subsets of non-Hodgkin's lymphoma with or without CD30 (Ki-1) expression and Hodgkin's disease. Modem Pathology 1995; 8: 118A
   Google Scholar
• Yee H. T., Ponzoni M., Merson A., Goldstein M., Scarpa A., Chilosi M., Menestrina F., Pittaluga S., De Wolf-Peeters C., Shiota M., Mori S., Frizzera G., Inghirami G. Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood 1996; 87: 1081–1088
   PubMed Web of Science ®Google Scholar
• Trumper L., Daus H., Merz H., von Bonin F., Loftin U., Cochlovius C., Moller P., Feller A., Pfreundschuh M. NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: Results from single-cell cDNA analysis. Annals of Oncology 1997; 8: 83–7
   PubMed Web of Science ®Google Scholar
• Sarris A. H., Jhanwar S. C., Cabanillas F. Cytogenetics of Hodgkin's Disease. Hodgkin's Disease, J.O.A. P.M. Mauch, V. Diehl, R. T. Hoppe, L. M. Weiss. Lippincott-Raven, New York 1999
   Google Scholar
• Herbst H., Anagnostopoulos J., Heinze B., Durkop H., Hummel M., Stein H. ALK Gene Products in Anaplastic Large Cell Lymphomas and Hodgkin's Disease. Blood 1995; 86: 1694–1700
   PubMed Web of Science ®Google Scholar
• Shi S., Key M., Karla K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for histochemical staining based on microwave oven heating of tissue sections. Journal of Histochemistry and Cytochemistry 1991; 39: 741
   PubMed Web of Science ®Google Scholar
• Gown A. M., De Weber N., Battifora H. Microwave-based antigen unmasking: A revolutionary new technique for routine immunohistochemistry. Applied Immunohistochemistry 1993; 1: 256–266
   Google Scholar
• Hagemeister F. B., Fuller L., McLaughlin P., Rodriguez M., Romaguera J., Swan F., Cabanillas F. NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis. Ann Oncol 1992; 4: 87–90
   Google Scholar
• Bonadonna G., Valagussa P., Santoro A. Alternating noncross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Ann Intern Med 1986; 104: 739–46
   PubMed Web of Science ®Google Scholar
• Delsol G., Lamant L., Mariame B., Pulford K., Dastugue N., Brousset P., Rigal-Huguet R, al Saati T., Cerretti D. P., Morris S. W., Mason D. Y. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997; 89: 1483–90
   PubMed Web of Science ®Google Scholar
• Straus D. J., Gaynor J. J., Myers J., Merke D. P., Caravelli J., Chapman D., Yahalom J., Clarkson B. D. Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. J Clin Oncol 1990; 8: 1173–86
   PubMed Web of Science ®Google Scholar
• Ladanyi M., Cavalchire G., Morris S. W., Downing J., Filippa D. A. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2; 5) translocation in Hodgkin's disease. American Journal of Pathology 1994; 145: 1296–300
   PubMed Web of Science ®Google Scholar
• Wellmann A., Clark H. M., Otsuki T., Jaffe E. S., Raffeld M. Detection of the t(2;5)(p23;q35) in classical anaplastic large cell lymphoma (ALCL) by reverse transcriptase-polymerase chain reaction. Modem Pathology 1995; 8: 123A
   Google Scholar
• Xerri L., Parc P., Hassoun J., Birnbaum D. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease. Journal of Pathology 1996; 178: 128–32
   PubMed Web of Science ®Google Scholar
• Wood G. Analysis of the t(2;5)(p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Leukemia and Lymphoma 1998; 29: 93–101
   PubMed Web of Science ®Google Scholar
• Weber-Matthiesen K., Deerberg-Wittram J., Rosenwald A., Poetsch M., Grote W., Schlegelberger B. Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics. American Journal of Pathology 1996; 149: 463–8
   PubMed Web of Science ®Google Scholar
• Waggott W., Delsol G., Jarret R.E, Mason D. Y., Garter K. C., Boultwood J., Wainscoat J. S. NPM-ALK gene fusion and Hodgkin's disease [letter]. Blood 1997; 90: 1712–3
   PubMed Web of Science ®Google Scholar
• Johnson P. W.M., Leek K., Swinbank K., Angus B., Roberts P., Markham A., Selby P., MacLennan K. A. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma. Annals of Oncology 1997, Suppl.2: S65–S69
   Google Scholar